Intrinsic Value of S&P & Nasdaq Contact Us

Immatics N.V. IMTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • DE • USD

SharesGrow Score
57/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.00
+91.8%

Immatics N.V. (IMTX) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.

The analyst consensus price target for IMTX is $21.00, representing a +91.8% upside from the current price of $10.95. Price targets range from a low of $17.00 to a high of $25.00.

Analyst Consensus — IMTX

Buy
Strong Buy
0
Buy
8
Hold
0
Sell
0
Strong Sell
0
8 analysts
Price Targets
Consensus$21.00
High$25.00
Low$17.00
Median$21.00
Last Month Avg-
Last Quarter Avg$25.00
Last Year Avg$19.25
All-Time Count6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message